OOIR: Observatory of International Research

Papers

(The H4-Index of Andrology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Cortisol modulates Ca²⁺ signaling and acrosome reaction in human sperm	66
A translation regulator that drives spermatogonial stem cell formation	64
Association between systemic immune inflammation index and serum testosterone and free testosterone in middle‐aged and elderly men	55
Excessive androgen exposure and risk of malignancies: A cohort study	55
Correction to ASA Meeting Abstracts 2023	51
Differential expression of metabolic enzymes in testicular germ cell tumors: The impact of glycolytic metabolism in embryonal carcinoma histotype	50
Cryopreservation of equine spermatozoa reduces plasma membrane integrity and phospholipase C zeta 1 content as associated with oocyte activation	45
The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 thresholds for normal semen parameters?	44
Congenital male genital malformations and paternal health: An analysis of the US claims data	44
Contraceptive efficacy: Determining the threshold for effective suppression based on sperm concentration, motility, and morphology	41
A prospective study of semen quality and fecundability among North American couples planning pregnancy	39
A homozygous loss‐of‐function mutation in CEP250 is associated with acephalic spermatozoa syndrome in humans	38
Spontaneous alterations in semen parameters are associated with age, accessory gland function and the FSHB c.‐211G>T variant	37
Genital gender‐affirming surgery trends in Germany: Total population data with 19,600 cases from 2006 to 2022	35
Influence of androgens on the innate immune system	35
The emergence of natural products as potential therapeutics for male infertility	35
Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research	34
The efficacy of PDE5 inhibitors in diabetic patients	34
Statutes of the European Academy of Andrology	33
Issue Information	32
Effects of chronic mild stress induced from peripuberty on sexual behavior in male rats, with or without escitalopram treatment	31
Identification of potential drug targets for erectile dysfunction with single‐cell RNA sequencing: A Mendelian randomization study	30
Disparity in hormone therapy acceptance between genders	29
PDE5is‐naïve versus non‐naïve patients at first investigation for erectile dysfunction—findings from a long‐term, real‐life cross‐sectional study	29
	28

Issue Information	28
Male contraception: Focus on behavioral and barrier methods	28
Healthy and unhealthy dietary patterns and sperm quality from the Led‐Fertyl study	27
The neurological decline and psychological factors caused by coronavirus disease 2019 may be predictors of erectile dysfunction	27
Therapeutic potential of hesperidin in diabetes mellitus‐induced erectile dysfunction through Nrf2‐mediated ferroptosis and oxidative stress	27